Novexel
Records under this name other than patents Novexel holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,288,553 | Method for preparing disubstituted piperidine and intermediates Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,835,455 | Novel Crystalline Forms of TRANS-7-OXO-6-(SULPHOOXY)-1,6-Diazabicyclo[3,2,1]OCTANE-2-Carboxamide Sodium Salt Formerly held In force · High confidence | In force | High confidence | |
| US 9,062,053 | Novel Crystalline Forms of TRANS-7-OXO-6-(SULPHOOXY)-1,6-Diazabicyclo[3,2,1]OCTANE-2-Carboxamide Sodium Salt Formerly held In force · High confidence | In force | High confidence | |
| US 9,580,424 | Novel Crystalline Forms of TRANS-7-OXO-6-(SULPHOOXY)-1,6-Diazabicyclo[3,2,1]OCTANE-2-Carboxamide Sodium Salt Formerly held In force · High confidence | In force | High confidence | |
| US 8,471,025 | Novel Crystalline Forms of TRANS-7-OXO-6-(SULPHOOXY)-1,6-Diazabicyclo[3,2,1]OCTANE-2-Carboxamide Sodium Salt Formerly held In force · High confidence | In force | High confidence | |
| US 7,612,087 | Heterocyclic Compounds as Inhibitors of Beta-Lactamases Formerly held Term ended Term ended Nov 12, 2026 · High confidence | Term ended | Term ended Nov 12, 2026 | High confidence |
| US 7,112,592 | Azabicyclic Compounds, Preparation Thereof and Use as Medicines, in Particular as Antibacterial Agents Formerly held Term ended Term ended Jan 7, 2026 · High confidence | Term ended | Term ended Jan 7, 2026 | High confidence |
| US 7,732,610 | Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents Formerly held Term ended Term ended Jun 23, 2022 · From the USPTO record | Term ended | Term ended Jun 23, 2022 | From the USPTO record |
| US 7,439,253 | Novel Heterocyclic Compounds, Their Preparation and Their Use as Medicaments, in Particular as Antibacterials and Beta-Lactamase Inhibitors Formerly held Lapsed on the fee record Ended Oct 21, 2020 · Medium confidence | Lapsed on the fee record | Ended Oct 21, 2020 | Medium confidence |
| US 6,541,451 | Streptogramin derivatives, their preparation and compositions containing them Term ended Term ended Aug 13, 2020 · From the USPTO record | Term ended | Term ended Aug 13, 2020 | From the USPTO record |